Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig C Earle

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
JAMA Surgery|September 5, 2019
Population-Level Symptom Assessment Following Pancreaticoduodenectomy for AdenocarcinomaStephanie Tung, Laura E Davis, Julie Hallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With CancerJavaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Cancer Epidemiology|January 15, 2019
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictionsMichael Eden, Samantha Harrison, Michelle Griffin, et al.
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment ExerciseWei Fang Dai, Erica Craig, Brent Fraser, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?Rui Fu, Rinku Sutradhar, Anna Dare, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2006
Hepatobiliary cancers. Clinical practice guidelines in oncologyAl B Benson, Tanios Bekaii-Saab, Edgar Ben-Josef, et al.
CMAJ Open|May 9, 2023
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
JAMA Surgery|September 5, 2019
Population-Level Symptom Assessment Following Pancreaticoduodenectomy for AdenocarcinomaStephanie Tung, Laura E Davis, Julie Hallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With CancerJavaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Cancer Epidemiology|January 15, 2019
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictionsMichael Eden, Samantha Harrison, Michelle Griffin, et al.
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment ExerciseWei Fang Dai, Erica Craig, Brent Fraser, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?Rui Fu, Rinku Sutradhar, Anna Dare, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2006
Hepatobiliary cancers. Clinical practice guidelines in oncologyAl B Benson, Tanios Bekaii-Saab, Edgar Ben-Josef, et al.
CMAJ Open|May 9, 2023
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort studyRui Fu, Rinku Sutradhar, Qing Li, et al.
Pageof 29